Position in INVA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,777,252
+$285,036 QoQ
Shares Held
210,359
+9.1% QoQ
Ownership
0.291%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 307 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 98%
None 2%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $5,025,615,702 across 202 Biotechnology names. INVA ranks #96 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,604,822 | $1,293,893,227 | |
| 2 | INSM |
INSMED Inc
|
6,179,571 | $658,865,856 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,215,523 | $292,904,576 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
1,039,702 | $194,715,388 | |
| 5 | ARGX |
Argenx SE
|
181,464 | $168,356,853 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
227,457 | $141,828,535 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
231,205 | $124,145,521 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,551,663 | $115,567,858 |
All Filings in INVA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,777,252 | 210,359 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $4,492,216 | 192,799 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,898,509 | 144,998 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,502,640 | 137,131 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,854,547 | 142,088 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,506,943 | 138,276 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $2,500,534 | 144,123 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,017,090 | 156,245 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,827,441 | 172,405 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,810,545 | 184,419 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,050,455 | 190,178 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,608,651 | 200,820 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,863,701 | 224,957 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,795,625 | 248,500 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $3,296,613 | 248,801 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,932,743 | 252,605 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,883,547 | 263,113 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $5,687,951 | 293,951 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,191,024 | 300,929 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,527,106 | 270,922 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,704,712 | 276,265 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,345,880 | 279,990 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $3,309,021 | 267,072 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $2,923,564 | 279,767 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $4,419,049 | 316,098 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $3,887,996 | 330,612 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||